SK biopharmaceuticals Co., Ltd. (326030) — research page
KR · kr-cm-kg/KOSPI/326030 · as of 2026-11-06
Identity and listing
The issuer is SK biopharmaceuticals Co., Ltd., listed on KOSPI under ticker 326030, ISIN KR7326030004, LEI 9845004573839986EA59. Its security type is Corporate, its sector is 자연과학 및 공학 연구개발업, and its jurisdiction is South Korea (DART filer with a corporate registration number). Its segment is not on the record. Its listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | SK biopharmaceuticals Co., Ltd. | source · 2026-11-06 |
| exchange | KOSPI | source · 2026-11-06 |
| ticker | 326030 | source · 2026-11-06 |
| ISIN | KR7326030004 | source · 2026-11-08 |
| LEI | 9845004573839986EA59 | source · 2026-11-06 |
| security type | Corporate | source · 2026-11-06 |
| segment | not on the record | |
| sector | 자연과학 및 공학 연구개발업 | source · 2026-11-06 |
| jurisdiction | South Korea (DART filer with a corporate registration number) | source · 2026-11-06 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 59 filings on 40 filing days in the twelve months to 2026-11-06. The median gap between filing days is 7 days. The latest filing is dated 2026-11-05 and is of type results, 1 day before the record date. Exchange peers on KOSPI carry 832 issuers, a median cadence gap of 7.0 days, a median of 49.0 filings and a median latency of 7.0 days. Sector peers carry 80 issuers, a median cadence gap of 7 days, a median of 42.5 filings and a median latency of 15 days.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 59 | 7 | 1 |
| exchange median: KOSPI (832 issuers) | 49 | 7 | 7 |
| sector median: 자연과학 및 공학 연구개발업 (80 issuers) | 42.5 | 7 | 15 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-05 | results | 연결재무제표기준영업(잠정)실적(공정공시) | |
| 2026-11-04 | corporate_news | 투자판단관련주요경영사항 (뇌전증 치료제 세노바메이트의 일차성 전신강직간대발작 적응증 미국 FDA 허가 신청) | |
| 2026-11-02 | corporate_news | 기업설명회(IR)개최(안내공시) | |
| 2026-09-10 | corporate_news | 기업설명회(IR)개최(안내공시) | |
| 2026-09-10 | corporate_news | 투자판단관련주요경영사항 (뇌전증 신약 후보 물질 Opakalim의 미국 FDA 임상 2/3상 Partial Clinical Hold 통보 수령) |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is 한영회계법인; its location is not on the record. Auditor changes are not on the record.
Events and halts
Listing, delisting, name change, domicile change and segment move are not on the record, because no lifecycle type map exists yet for this register. The halt flag reads listed, not halted.
Orderability
The outcome is not determinable for this issuer because the chapter's orderability section carries no client_categories, so the outcome cannot name its client category. The rule version is acm-68000/kr/suitability-and-appropriateness-fscma-articles-46-and-46-2/r1, with the chapter as of 2026-11-04.
rule acm-68000/kr/suitability-and-appropriateness-fscma-articles-46-and-46-2/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
The field has not been read.
Open research
The field has not been read.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The vintage of this market is not sealed. The live record began on 2026-09-12. Years 2021, 2022, 2023, 2024, 2025 and 2026 are sealed in the store but are not served as of a date; the as-of door answers not_sealed.
Sources
9 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://kind.krx.co.kr/corpgeneral/corpList.do?method=download&searchType=13 (identity.exchange)
- 10.2
- https://data.krx.co.kr/comm/bldAttendant/getJsonData.cmd (identity.isin)
- 10.3
- https://opendart.fss.or.kr/api/company.json?corp_code=00878696 (identity.jurisdiction)
- 10.4
- https://api.gleif.org/api/v1/lei-records/9845004573839986EA59 (identity.lei)
- 10.5
- https://mcp.kr-cm-kg.ai/events/KOSPI/326030 (the disclosure lines)
- 10.6
- https://kind.krx.co.kr/investwarn/tradinghaltissue.do?method=searchTradingHaltIssueMain (the halt flag)
- 10.7
- https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260318000773 (the auditor)
- 10.8
- https://mcp.kr-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.9
- https://mcp.kr-cm-kg.ai/record/KOSPI/326030 (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getissuer.ai/mcp with {"isin":"KR7326030004"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:a333dbf07a3d60c2.